Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from <scp>CheckMate</scp> 816Tetsuya Mitsudomi, Fumihiro Tanaka, Hiroyuki Ito et al.|Cancer Science|2023Cited by 27
P1.07.49 Limited Impact of Adjuvant Chemotherapy in Alk-Positive Stage II-III Adenocarcinoma: A Multicenter CReGYT-03 ALK StudyAkira Hamada, Y. Tsutani, Shinya Katsumata et al.|Journal of Thoracic Oncology|2025Cited by 0